Ardx marketwatch.

Ardelyx (ARDX) closed the most recent trading day at $2.95, moving +0.34% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.16%. At the same time, the Dow lost 0. ... Ardelyx Inc. SEC filings breakout by MarketWatch. View the ARDX U.S. Securities and Exchange Commission reporting information. Ardelyx Inc. Quarterly balance sheet by MarketWatch. View all ARDX assets, cash, debt, liabilities, shareholder equity and investments.View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

See Ardelyx, Inc. (ARDX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Ardelyx (ARDX Quick Quote ARDX - Free Report) reported $34.36 million in revenue for the quarter ended December 2023, representing a year-over-year decline of 22.2%.EPS of -$0.12 for the same ...

Billion Dollar Secret. View Ardelyx, Inc ARDX investment & stock information. Get the latest Ardelyx, Inc ARDX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Ardelyx Inc. company facts, information and financial ratios from MarketWatch.ARDX stock closed at $5.91 and is up $0.24 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARDX has a strong overall score of 86 meaning the stock holds a better value than 86% of stocks at its current price. InvestorsObserver's ...Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. Finviz Elite. 09:57AM. Wedbush Adjusts Ardelyx's Price Target to $15 From $14, Keeps Outperform Rating. (MT Newswires) 07:31AM. Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday. (InvestorPlace)Oct 17, 2023 · Ardelyx Inc. ARDX, +0.62% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease. The biopharma company said late Tuesday ... While Ardelyx, Inc. (NASDAQ:ARDX) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 23% in the last quarter. While that's ...

Ardelyx, Inc. Common Stock (ARDX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

COMS | Complete COMSovereign Holding Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Nov 17, 2022 · Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that benefits of ... AQSTAquestive Therapeutics, Inc. 3.2700. +5.83%. Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing.MarketWatch · 2024/04/12 16:50 · 花旗集團2024年第一季度業績和關鍵指標. moomoo資訊 · 2024/04/12 05:00 · 橡膠手套行業最黑暗的時刻已經過去了嗎？分析師的見解. 專欄 ...Ardelyx Inc. company facts, information and financial ratios from MarketWatch.VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

ARDS | Complete Aridis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Ardelyx Inc. Annual cash flow by MarketWatch. View ARDX net cash flow, operating cash flow, operating expenses and cash dividends.267. Get the latest Ardelyx Inc (ARDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Q1 net loss was $26.8 million, but Ardelyx raised $51.9 million through sales of their common stock at an average price of about $3.35, leaving $130.4 million in total cash and investments as of ... Ardelyx Inc. company facts, information and financial ratios from MarketWatch. Oct 17, 2023 · Ardelyx Inc. (ARDX) on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease. The biopharma company said late Tuesday that ...

Ardelyx Inc. Quarterly cash flow by MarketWatch. View ARDX net cash flow, operating cash flow, operating expenses and cash dividends. Mar 10, 2023 ... ARDX = mO,X. MO. 1.5· mFe. MFe. ∗ 100%. (9) ... ARDX. (11). The utilization degree of hydrogen ... Carbon Market Watch. Decarbonising Steel ...

Ardelyx Inc. company facts, information and financial ratios from MarketWatch. 3.16 to 10.13. News | Industry | Market Advisers | Analysts | SEC Filings | Insiders | Annual Report | Profile. Create Alert | Go to Watchlist | Technical Analysis. email this chart printer-friendly format. ARDX - Ardelyx Inc. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. View Ardelyx, Inc. ARDX stock quote prices, financial information, real-time forecasts, and company news from CNN.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.A high-level overview of Ardelyx, Inc. (ARDX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.VRSK | Complete Verisk Analytics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

MarketWatch Dow Jones Argenx stock dives by a third after late-stage trial didn’t meet goals Dec. 20, 2023 at 4:22 a.m. ET by Steve Goldstein

Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop …

MADE IN THE USA. 40+ Years of High Quality Design & Manufacturing. Manufactured in Winters, Texas. Our Products.1.16%. $70.89B. AMZN | Complete Amazon.com Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Trending Tickers. Above average volume. AXTI $3.54. 16.83% 0.51 · ARDX $8.47. 24.74% 1.68 · WOW $4.35. 14.78% 0.56 · EBS $3.26. -1.21% -0.04 · Access Pr...Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Feb 28, 2023 ... ARDX at $4 and BLPH $6.78 are on the monitor. ... https://bigcharts.marketwatch.com/advchart ... ASRT $6.37 ARDX $4.79 BLPH $7.89. Upvote 1Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.

Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that benefits of ...According to the issued ratings of 9 analysts in the last year, the consensus rating for Ardelyx stock is Buy based on the current 8 buy ratings and 1 strong buy rating for ARDX. The average twelve-month price prediction for Ardelyx is $12.81 with a high price target of $15.00 and a low price target of $8.50. Learn more on ARDX's analyst rating ...Ardelyx, Inc. (ARDX) Add to watchlist. NasdaqGM - NasdaqGM Real Time Price. Currency in USD. 8.48 -0.83 (-8.92%) At close: 04:00PM EDT. 8.46 -0.02 (-0.24%) After hours: 07:58PM EDT. P. O. H. L....Instagram:https://instagram. lowe's home improvement smokey park highway asheville ncpowerbeats how to pairclay county florida trash pickupwip radio lineup Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Ardelyx (ARDX Quick Quote ARDX - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy).This upgrade is essentially a reflection of an upward trend in ... diamondback firearms reviewcarrabba's johnson city menu Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on December 18, 2023 ... mullet fades New York Community Bancorp Inc. $4.06. 1.89M. 0.17. 4.36%. Monitor leaders, laggards and most active stocks during after-market hours trading.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.